EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Role of liver X receptors in the pathogenesis and treatment of chronic liver disease (Review)

Honghui You, Xiangjun Tang, Xiaoyan Fu, Jiaqi Zhou, Liyuan Wang, Hongxia Zhang, Xianhong Du, Shujuan Liang, Meifang Liu

Molecular Medicine Reports · 19.03.2026 · 33 (5) · 1-14

DOI: 10.3892/mmr.2026.13848 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, online erschienen am 19.03.2026. Verfasst von Honghui You und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, School of Basic Medical Sciences, S…. Hauptthemen laut MEDLINE: Liver X Receptors, Liver Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver X receptors (LXRs), transcription factors belonging to the nuclear receptor superfamily, exist as two isoforms, LXRα (NR1H3) and LXRβ (NR1H2), that orchestrate cholesterol absorption, transport and excretion. Beyond their canonical roles in lipid homeostasis, LXRs modulate glucose metabolism, inflammatory responses and cellular proliferation. Emerging evidence implicates dysregulated LXRs activity in the pathogenesis of chronic liver diseases (CLDs), including viral hepatitis, metabolic dysfunction‑associated steatotic liver disease and hepatocellular carcinoma. However, the therapeutic potential of LXRs modulation remains paradoxical: While activation mitigates hepatic injury by maintaining cholesterol homeostasis and suppressing inflammation, concurrent upregulation of sterol regulatory element‑binding protein 1c exacerbates lipogenesis, potentially aggravating hepatosteatosis. The present review synthesized current insights into the dual regulatory mechanisms of LXRs in CLDs, critically evaluates their context‑dependent roles and highlights the imperative to balance therapeutic efficacy with metabolic side effects in future drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver X ReceptorsLiver DiseasesHumansAnimalsLipid MetabolismCholesterolChronic DiseaseLiver NeoplasmsCarcinoma, Hepatocellular

Stichwörter der Autor:innen

cholesterol metabolismchronic liver diseasehepatocellular carcinomalipid metabolismliver X receptors

Substanzen

Liver X ReceptorsCholesterol

Autor:innen und Institutionen

  • Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, School of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong 261053, P.R. Chin…
  • Department of Nephrology, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong 261041, P.R. China.

Zitieren

APA

You, H., Tang, X., Fu, X., Zhou, J., Wang, L., Zhang, H., Du, X., Liang, S., & Liu, M. (2026). Role of liver X receptors in the pathogenesis and treatment of chronic liver disease (Review). Molecular Medicine Reports, 33(5), 1-14. https://doi.org/10.3892/mmr.2026.13848

Vancouver

You H, Tang X, Fu X, Zhou J, Wang L, Zhang H, et al. Role of liver X receptors in the pathogenesis and treatment of chronic liver disease (Review). Molecular Medicine Reports. 2026;33(5):1-14. doi:10.3892/mmr.2026.13848

BibTeX
@article{You2026,
  author = {You, Honghui and Tang, Xiangjun and Fu, Xiaoyan and Zhou, Jiaqi and Wang, Liyuan and Zhang, Hongxia and Du, Xianhong and Liang, Shujuan and Liu, Meifang},
  title = {Role of liver X receptors in the pathogenesis and treatment of chronic liver disease (Review)},
  journal = {Molecular Medicine Reports},
  year = {2026},
  volume = {33},
  number = {5},
  pages = {1--14},
  doi = {10.3892/mmr.2026.13848}
}
Kostenlos starten →